New insights into the role of the GABAA–benzodiazepine receptor in psychiatric disorder

David J. Nutt; Andrea L. Malizia

doi:10.1192/bjp.179.5.390

Argyropoulos, S.V. and Nutt, D.J. 2002. Anxiety Disorders. p. 181.

Faravelli, C. Rosi, S. and Truglia, E. 2002. Anxiety Disorders. p. 313.

Möhler, Hanns 2002. Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology. Dialogues in Clinical Neuroscience, Vol. 4, Issue. 3, p. 261.

Nutt, D. and Ballenger, J. 2002. Anxiety Disorders. p. 499.

Paton, Carol 2002. Benzodiazepines and disinhibition: a review. Psychiatric Bulletin, Vol. 26, Issue. 12, p. 460.

Steimer, Thierry 2002. The biology of fear- and anxiety-related behaviors. Dialogues in Clinical Neuroscience, Vol. 4, Issue. 3, p. 231.

Lingford-Hughes, Anne Hume, Susan P. Feeney, Adrian Hirani, Ella Osman, Safiye Cunningham, Vincent J. Pike, Victor W. Brooks, David J. and Nutt, David J. 2002. Imaging the GABA-Benzodiazepine Receptor Subtype Containing the α5-Subunit In Vivo with [11C]Ro15 4513 Positron Emission Tomography. Journal of Cerebral Blood Flow & Metabolism, Vol. 22, Issue. 7, p. 878.

Kopanitsa, M.V. Yakubovska, L.M. Rudenko, O.P. and Krishtal, O.A. 2002. Modulation of GABAA receptor-mediated currents by benzophenone derivatives in isolated rat Purkinje neurones. Neuropharmacology, Vol. 43, Issue. 4, p. 764.

Blankenberg, Francis G. and Strauss, H. William 2002. Nuclear medicine applications in molecular imaging. Journal of Magnetic Resonance Imaging, Vol. 16, Issue. 4, p. 352.

Daglish, Mark R.C. and Nutt, David J. 2003. Brain imaging studies in human addicts. European Neuropsychopharmacology, Vol. 13, Issue. 6, p. 453.

Raud, Sirli Rünkorg, Kertu Veraksitš, Alar Reimets, Ain Nelovkov, Aleksei Abramov, Urho Matsui, Toshimitsu Bourin, Michel Volke, Vallo Kõks, Sulev and Vasar, Eero 2003. Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice. Psychopharmacology, Vol. 168, Issue. 4, p. 417.

Rivas-Vazquez, Rafael A. 2003. Benzodiazepines in contemporary clinical practice.. Professional Psychology: Research and Practice, Vol. 34, Issue. 3, p. 324.

Holmes, Andrew and Rodgers, R.John 2003. Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. European Journal of Pharmacology, Vol. 459, Issue. 2-3, p. 221.

Allgulander, Christer Bandelow, Borwin Hollander, Eric Montgomery, Stuart A. Nutt, David J. Okasha, Ahmed Pollack, Mark H. Stein, Dan J. and Swinson, Richard P. 2003. WCA Recommendations for the Long-Term Treatment of Generalized Anxiety Disorder. CNS Spectrums, Vol. 8, Issue. S1, p. 53.

Millan, Mark J. 2003. The neurobiology and control of anxious states. Progress in Neurobiology, Vol. 70, Issue. 2, p. 83.

Rupprecht, R. and Zwanzger, P. 2003. Die Bedeutung von GABAA-Rezeptoren für Pathophysiologie und Therapie der Panikstörung. Der Nervenarzt, Vol. 74, Issue. 7, p. 543.

Obradovic, Dragan Savic, Miroslav Ugresic, Nenad and Bokonjic, Dubravko 2003. GABAa receptori - molekulski supstrat za razvoj novih anksiolitika. Vojnosanitetski pregled, Vol. 60, Issue. 3, p. 345.

Blankenberg, Francis G. 2003. Molecular imaging: The latest generation of contrast agents and tissue characterization techniques. Journal of Cellular Biochemistry, Vol. 90, Issue. 3, p. 443.

Lingford-Hughes, Anne and Nutt, David 2003. Neurobiology of addiction and implications for treatment. British Journal of Psychiatry, Vol. 182, Issue. 2, p. 97.

Nutt, David J. 2003. Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors. Journal of Psychopharmacology, Vol. 17, Issue. 4, p. 355.

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests